Apogee Therapeutics, Inc. Common Stock (APGE) — Long-term Investment Intensity
Apogee Therapeutics, Inc. Common Stock (APGE) has a Long-term Investment Intensity of 15.3% as of March 2026. Long-term investments of $198.35 Million represent 15.3% of total assets of $1.29 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Apogee Therapeutics, Inc. Common Stock (APGE) asset resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Apogee Therapeutics, Inc. Common Stock Long-term Investment Intensity (2024–2025)
This chart shows how Apogee Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the intensity stands at 15.3%, reflecting long-term investments of $198.35 Million against total assets of $1.29 Billion USD. For the complete balance sheet picture, see how large is Apogee Therapeutics, Inc. Common Stock's balance sheet.
Annual Long-term Investment Intensity for Apogee Therapeutics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Long-term Investment Intensity for Apogee Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Apogee Therapeutics, Inc. Common Stock balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 18.4% | $172.73 Million | $937.13 Million | ▼ -9.5 pp |
| 2024 | 27.9% | $210.42 Million | $753.95 Million | — |